Search type: go_term
Results for query: inflammatory response
| Gene Symbol | Gene Name | Links to Senescence |
|---|---|---|
| ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
U: 2
|
| ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 |
U: 2
D: 1
|
| ABCF1 | ATP binding cassette subfamily F member 1 |
U: 1
|
| ABR | active BCR-related gene |
U: 2
|
| ACE2 | angiotensin I converting enzyme 2 |
U: 1
|
| ACER3 | alkaline ceramidase 3 |
D: 2
|
| ACKR2 | atypical chemokine receptor 2 |
U: 1
|
| ACOD1 | aconitate decarboxylase 1 | |
| ACP5 | acid phosphatase 5, tartrate resistant |
U: 5
|
| ACVR1 | activin A receptor, type 1 |
U: 1
|
| ADA | adenosine deaminase |
D: 1
|
| ADAM8 | a disintegrin and metallopeptidase domain 8 |
D: 1
|
| ADAMTS12 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 12 |
U: 1
D: 1
|
| ADCY7 | adenylate cyclase 7 |
U: 1
|
| ADGRE2 | adhesion G protein-coupled receptor E2 |
U: 1
|
| ADGRE5 | adhesion G protein-coupled receptor E5 |
U: 1
D: 1
|
| ADIPOQ | adiponectin, C1Q and collagen domain containing |
U: 2
D: 4
|
| ADM | adrenomedullin |
U: 4
D: 2
|
| ADORA1 | adenosine A1 receptor |
D: 1
|
| ADORA2B | adenosine A2b receptor |
U: 2
D: 1
|
| AFAP1L2 | actin filament associated protein 1-like 2 |
U: 1
D: 1
|
| AGER | advanced glycosylation end product-specific receptor |
U: 2
D: 1
|
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
U: 4
D: 1
|
| AGTR1 | angiotensin II receptor type 1 |
U: 6
D: 2
|
| AGTR2 | angiotensin II receptor, type 2 |
D: 1
|
| AHCY | S-adenosylhomocysteine hydrolase |
U: 2
D: 1
|
| AIM2 | absent in melanoma 2 |
U: 1
|
| AIMP1 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
D: 1
|
| AKT1 | thymoma viral proto-oncogene 1 |
U: 21
D: 24
|
| ALOX15 | arachidonate 15-lipoxygenase |
U: 1
|
| ALOX5 | arachidonate 5-lipoxygenase |
U: 2
|
| ANXA1 | annexin A1 |
U: 2
D: 1
|
| AOC3 | amine oxidase, copper containing 3 |
U: 1
D: 2
|
| APOA1 | apolipoprotein A-I |
U: 3
|
| APOD | apolipoprotein D |
U: 3
D: 1
|
| APOE | apolipoprotein E |
U: 4
D: 2
|
| APOL3 | apolipoprotein L3 |
U: 1
D: 1
|
| APPL1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
D: 2
|
| APPL2 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 |
D: 1
|
| ATRN | attractin |
U: 2
|
| AXL | AXL receptor tyrosine kinase |
U: 1
D: 4
|
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
U: 3
|
| ADAM17 | a disintegrin and metallopeptidase domain 17 |
U: 3
D: 2
|
| ADRA2A | adrenergic receptor, alpha 2a |
U: 2
|
| ADRB2 | adrenergic receptor, beta 2 |
U: 1
D: 1
|
| ALDH2 | aldehyde dehydrogenase 2, mitochondrial |
U: 3
D: 1
|
| ALOX5AP | arachidonate 5-lipoxygenase activating protein |
U: 4
D: 1
|
| ANKRD42 | ankyrin repeat domain 42 |
U: 1
|
| B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
U: 2
|
| BCL6 | B cell leukemia/lymphoma 6 |
U: 3
D: 1
|
| BCL6B | B cell CLL/lymphoma 6, member B |
U: 1
D: 1
|
| BCR | BCR activator of RhoGEF and GTPase |
U: 1
|
| BDKRB1 | bradykinin receptor, beta 1 |
D: 1
|
| BIRC2 | baculoviral IAP repeat containing 2 |
U: 1
D: 1
|
| BIRC3 | baculoviral IAP repeat containing 3 |
U: 3
D: 2
|
| BMP2 | bone morphogenetic protein 2 |
U: 6
D: 1
|
| BMP6 | bone morphogenetic protein 6 |
U: 2
D: 1
|
| BMPR1B | bone morphogenetic protein receptor, type 1B |
D: 1
|
| BRD4 | bromodomain containing 4 |
U: 1
D: 5
|
| BST1 | bone marrow stromal cell antigen 1 |
U: 2
|
| C1QTNF12 | C1q and tumor necrosis factor related 12 | |
| C2CD4B | C2 calcium-dependent domain containing 4B |
U: 1
|
| C3 | complement C3 |
U: 9
D: 1
|
| C3AR1 | complement component 3a receptor 1 |
U: 1
|
| C4A | complement C4A (Rodgers blood group) |
U: 1
D: 1
|
| C4B | complement C4B (Chido blood group) |
D: 1
|
| C5 | complement C5 |
U: 1
D: 4
|
| C5AR1 | complement component 5a receptor 1 |
U: 2
D: 1
|
| C5AR2 | complement component 5a receptor 2 |
U: 2
|
| CALCA | calcitonin/calcitonin-related polypeptide, alpha |
D: 3
|
| CALCRL | calcitonin receptor-like |
D: 3
|
| CAMK4 | calcium/calmodulin-dependent protein kinase IV |
D: 3
|
| CASP1 | caspase 1 |
U: 2
D: 3
|
| CASP4 | caspase 4, apoptosis-related cysteine peptidase |
U: 2
D: 2
|
| CASP5 | caspase 5 |
U: 1
|
| CCL1 | chemokine (C-C motif) ligand 1 |
U: 3
|
| CCL11 | chemokine (C-C motif) ligand 11 |
U: 5
D: 1
|
| CCL13 | C-C motif chemokine ligand 13 |
U: 2
D: 1
|
| CCL17 | chemokine (C-C motif) ligand 17 |
U: 1
D: 1
|
| CCL2 | chemokine (C-C motif) ligand 2 |
U: 39
D: 6
|
| CCL20 | chemokine (C-C motif) ligand 20 |
U: 9
|
| CCL26 | chemokine (C-C motif) ligand 26 |
U: 1
|
| CCL3 | chemokine (C-C motif) ligand 3 |
U: 11
D: 1
|
| CCL3L3 | C-C motif chemokine ligand 3 like 3 |
U: 2
|
| CCL4 | chemokine (C-C motif) ligand 4 |
U: 5
|
| CCL5 | chemokine (C-C motif) ligand 5 |
U: 13
D: 1
|
| CCL7 | chemokine (C-C motif) ligand 7 |
U: 7
|
| CCL8 | chemokine (C-C motif) ligand 8 |
U: 5
|
| CCN3 | cellular communication network factor 3 |
U: 1
|
| CCN4 | cellular communication network factor 4 | |
| CCR1 | chemokine (C-C motif) receptor 1 |
U: 2
D: 1
|
| CCR7 | chemokine (C-C motif) receptor 7 |
U: 2
D: 1
|
| CD14 | CD14 antigen |
U: 2
|
| CD180 | CD180 antigen |
D: 1
|
| CD28 | CD28 antigen |
U: 1
D: 2
|
| CD36 | CD36 molecule |
U: 4
D: 2
|
| CD40 | CD40 antigen |
U: 1
|
| CD40LG | CD40 ligand |
U: 1
|
| CD44 | CD44 antigen |
U: 6
D: 2
|
| CD47 | CD47 antigen (Rh-related antigen, integrin-associated signal transducer) |
U: 2
|
| CD6 | CD6 antigen |
U: 1
|
| CD68 | CD68 antigen |
U: 3
D: 3
|
| CD81 | CD81 antigen |
U: 2
D: 1
|
| CD96 | CD96 antigen |
D: 1
|
| CDH5 | cadherin 5 |
U: 1
D: 3
|
| CDO1 | cysteine dioxygenase type 1 |
D: 1
|
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha |
U: 4
D: 1
|
| CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
U: 9
D: 1
|
| CELA1 | chymotrypsin-like elastase family, member 1 |
U: 1
|
| CERS6 | ceramide synthase 6 |
U: 1
|
| CHI3L1 | chitinase 3 like 1 |
U: 4
|
| CHID1 | chitinase domain containing 1 |
U: 1
|
| CHST1 | carbohydrate sulfotransferase 1 |
U: 1
D: 1
|
| CHST2 | carbohydrate sulfotransferase 2 |
U: 2
D: 3
|
| CHUK | component of inhibitor of nuclear factor kappa B kinase complex |
U: 2
D: 2
|
| CIITA | class II transactivator |
D: 1
|
| CMKLR1 | chemokine-like receptor 1 |
U: 1
D: 2
|
| CNR1 | cannabinoid receptor 1 (brain) |
D: 1
|
| CRH | corticotropin releasing hormone |
D: 1
|
| CRHBP | corticotropin releasing hormone binding protein |
U: 2
|
| CRP | C-reactive protein |
U: 1
|
| CSF1 | colony stimulating factor 1 (macrophage) |
U: 5
|
| CSF1R | colony stimulating factor 1 receptor |
U: 1
D: 2
|
| CSRP3 | cysteine and glycine-rich protein 3 |
U: 1
D: 2
|
| CTNNBIP1 | catenin beta interacting protein 1 |
U: 1
D: 1
|
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 |
U: 4
|
| CXCL1 | chemokine (C-X-C motif) ligand 1 |
U: 27
D: 7
|
| CXCL10 | chemokine (C-X-C motif) ligand 10 |
U: 11
|
| CXCL11 | chemokine (C-X-C motif) ligand 11 |
U: 3
|
| CXCL13 | chemokine (C-X-C motif) ligand 13 |
U: 2
|
| CXCL2 | chemokine (C-X-C motif) ligand 2 |
U: 16
D: 5
|
| CXCL3 | chemokine (C-X-C motif) ligand 3 |
U: 5
D: 1
|
| CXCL5 | chemokine (C-X-C motif) ligand 5 |
U: 9
D: 1
|
| CXCL6 | C-X-C motif chemokine ligand 6 |
U: 7
|
| CXCL8 | C-X-C motif chemokine ligand 8 |
U: 49
D: 11
|
| CXCL9 | chemokine (C-X-C motif) ligand 9 |
U: 3
|
| CXCR2 | chemokine (C-X-C motif) receptor 2 |
U: 5
|
| CXCR3 | chemokine (C-X-C motif) receptor 3 |
U: 1
|
| CXCR4 | C-X-C motif chemokine receptor 4 |
U: 6
D: 2
|
| CXCR6 | chemokine (C-X-C motif) receptor 6 |
D: 1
|
| CYBA | cytochrome b-245, alpha polypeptide |
U: 1
D: 1
|
| CYBB | cytochrome b-245, beta polypeptide |
U: 3
D: 1
|
| CYLD | CYLD lysine 63 deubiquitinase |
U: 2
|
| CYP19A1 | cytochrome P450, family 19, subfamily a, polypeptide 1 |
U: 2
|
| CYP26B1 | cytochrome P450, family 26, subfamily b, polypeptide 1 |
U: 3
D: 1
|
| CYP4F11 | cytochrome P450 family 4 subfamily F member 11 |
D: 1
|
| CYSLTR1 | cysteinyl leukotriene receptor 1 |
D: 1
|
| CAMP | cathelicidin antimicrobial peptide |
U: 1
D: 1
|
| CCL9 | chemokine (C-C motif) ligand 9 |
U: 1
|
| CD276 | CD276 antigen |
U: 1
D: 1
|
| CFH | complement component factor h |
U: 3
D: 3
|
| CHRNA7 | cholinergic receptor, nicotinic, alpha polypeptide 7 |
U: 2
D: 1
|
| CLCF1 | cardiotrophin-like cytokine factor 1 |
U: 1
|
| CSPG4 | chondroitin sulfate proteoglycan 4 |
U: 5
D: 1
|
| CTSS | cathepsin S |
U: 5
|
| DAB2IP | disabled 2 interacting protein |
U: 1
D: 1
|
| DDT | D-dopachrome tautomerase |
U: 1
|
| DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 |
D: 2
|
| DPEP1 | dipeptidase 1 |
U: 1
D: 2
|
| DROSHA | drosha, ribonuclease type III |
D: 1
|
| DUOXA1 | dual oxidase maturation factor 1 |
U: 1
|
| DUSP10 | dual specificity phosphatase 10 |
U: 2
D: 1
|
| DICER1 | dicer 1, ribonuclease type III |
D: 6
|
| ECM1 | extracellular matrix protein 1 |
U: 4
|
| EGFR | epidermal growth factor receptor |
U: 2
D: 11
|
| EIF2AK1 | eukaryotic translation initiation factor 2 alpha kinase 1 |
U: 1
|
| ELANE | elastase, neutrophil expressed |
U: 1
D: 1
|
| ELF3 | E74-like factor 3 |
U: 2
|
| ENPP3 | ectonucleotide pyrophosphatase/phosphodiesterase 3 |
D: 1
|
| EPHA2 | Eph receptor A2 |
U: 2
D: 2
|
| ESR1 | estrogen receptor 1 (alpha) |
U: 2
D: 4
|
| ETS1 | E26 avian leukemia oncogene 1, 5' domain |
U: 2
D: 2
|
| EDNRA | endothelin receptor type A |
D: 5
|
| F11R | F11 receptor |
U: 3
|
| F2 | coagulation factor II, thrombin |
U: 2
|
| F2R | coagulation factor II (thrombin) receptor |
U: 2
D: 1
|
| F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
U: 2
D: 1
|
| F3 | coagulation factor III, tissue factor |
U: 2
D: 2
|
| FABP4 | fatty acid binding protein 4, adipocyte |
D: 4
|
| FANCA | Fanconi anemia, complementation group A |
D: 4
|
| FANCD2 | Fanconi anemia, complementation group D2 |
U: 2
D: 7
|
| FFAR4 | free fatty acid receptor 4 |
U: 1
|
| FNDC4 | fibronectin type III domain containing 4 |
U: 3
|
| FOS | Fos proto-oncogene, AP-1 transcription factor subunit |
U: 3
D: 8
|
| FOXF1 | forkhead box F1 |
U: 2
D: 1
|
| FOXP1 | forkhead box P1 |
U: 2
D: 3
|
| FOXP3 | forkhead box P3 |
U: 1
|
| FPR1 | formyl peptide receptor 1 |
U: 1
|
| FGFR1 | fibroblast growth factor receptor 1 |
U: 2
|
| GAL | galanin and GMAP prepropeptide |
U: 2
|
| GATA3 | GATA binding protein 3 |
U: 1
|
| GBA | glucosylceramidase beta |
U: 3
D: 1
|
| GGT1 | gamma-glutamyltransferase 1 |
U: 2
|
| GGT3P | gamma-glutamyltransferase 3 pseudogene |
U: 1
|
| GGT5 | gamma-glutamyltransferase 5 |
D: 1
|
| GJA1 | gap junction protein, alpha 1 |
U: 2
D: 2
|
| GPER1 | G protein-coupled estrogen receptor 1 |
U: 1
D: 1
|
| GPR17 | G protein-coupled receptor 17 |
D: 1
|
| GPR68 | G protein-coupled receptor 68 |
U: 1
|
| GPRC5B | G protein-coupled receptor, family C, group 5, member B |
U: 1
D: 1
|
| GPSM3 | G-protein signalling modulator 3 (AGS3-like, C. elegans) |
D: 1
|
| GPX1 | glutathione peroxidase 1 |
U: 4
D: 7
|
| GPX4 | glutathione peroxidase 4 |
U: 1
D: 1
|
| GRN | granulin |
U: 3
D: 1
|
| GSTP1 | glutathione S-transferase, pi 1 |
U: 1
|
| HAVCR2 | hepatitis A virus cellular receptor 2 |
U: 3
|
| HDAC4 | histone deacetylase 4 |
U: 1
D: 6
|
| HDAC5 | histone deacetylase 5 |
U: 2
D: 1
|
| HDAC9 | histone deacetylase 9 |
U: 1
D: 2
|
| HGF | hepatocyte growth factor |
U: 4
D: 2
|
| HIF1A | hypoxia inducible factor 1, alpha subunit |
U: 4
D: 8
|
| HK1 | hexokinase 1 |
U: 1
|
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 |
U: 2
D: 2
|
| HMGB1 | high mobility group box 1 |
U: 5
D: 8
|
| HMGB2 | high mobility group box 2 |
U: 1
D: 9
|
| HMOX1 | heme oxygenase 1 |
U: 5
D: 6
|
| HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 |
D: 1
|
| HP | haptoglobin |
U: 2
D: 1
|
| HSPD1 | heat shock protein 1 (chaperonin) |
U: 1
D: 3
|
| HSPG2 | heparan sulfate proteoglycan 2 |
U: 3
D: 1
|
| HYAL1 | hyaluronoglucosaminidase 1 |
U: 1
|
| HYAL2 | hyaluronoglucosaminidase 2 |
U: 2
|
| HDAC7 | histone deacetylase 7 |
D: 1
|
| HPS1 | HPS1, biogenesis of lysosomal organelles complex 3 subunit 1 |
U: 1
D: 1
|
| ICAM1 | intercellular adhesion molecule 1 |
U: 16
D: 1
|
| IDO1 | indoleamine 2,3-dioxygenase 1 |
U: 1
D: 3
|
| IFI16 | interferon gamma inducible protein 16 |
U: 4
D: 2
|
| IFNG | interferon gamma |
U: 13
|
| IGFBP4 | insulin like growth factor binding protein 4 |
U: 6
D: 2
|
| IKBKB | inhibitor of nuclear factor kappa B kinase subunit beta |
U: 2
D: 1
|
| IKBKG | inhibitor of nuclear factor kappa B kinase regulatory subunit gamma |
D: 1
|
| IL10 | interleukin 10 |
U: 4
D: 3
|
| IL13 | interleukin 13 |
U: 3
|
| IL15 | interleukin 15 |
U: 5
D: 1
|
| IL16 | interleukin 16 |
U: 1
D: 3
|
| IL17D | interleukin 17D |
U: 1
D: 1
|
| IL17RA | interleukin 17 receptor A |
U: 2
|
| IL17RB | interleukin 17 receptor B |
U: 1
D: 1
|
| IL17RC | interleukin 17 receptor C |
U: 2
D: 1
|
| IL17RE | interleukin 17 receptor E |
U: 1
|
| IL18 | interleukin 18 |
U: 8
D: 1
|
| IL18R1 | interleukin 18 receptor 1 |
U: 2
D: 2
|
| IL1A | interleukin 1 alpha |
U: 31
D: 6
|
| IL1B | interleukin 1 beta |
U: 48
D: 9
|
| IL1R1 | interleukin 1 receptor, type I |
U: 1
D: 1
|
| IL1R2 | interleukin 1 receptor, type II |
U: 1
D: 1
|
| IL1RAP | interleukin 1 receptor accessory protein |
U: 3
D: 2
|
| IL1RL1 | interleukin 1 receptor-like 1 |
U: 1
D: 1
|
| IL1RN | interleukin 1 receptor antagonist |
U: 4
D: 1
|
| IL2 | interleukin 2 |
U: 3
D: 2
|
| IL20 | interleukin 20 |
U: 1
|
| IL20RB | interleukin 20 receptor beta |
U: 1
D: 1
|
| IL22 | interleukin 22 |
U: 2
D: 1
|
| IL23A | interleukin 23, alpha subunit p19 |
U: 5
D: 1
|
| IL23R | interleukin 23 receptor |
U: 1
|
| IL31RA | interleukin 31 receptor A |
U: 1
D: 1
|
| IL33 | interleukin 33 |
U: 1
D: 2
|
| IL34 | interleukin 34 |
U: 2
D: 1
|
| IL36B | interleukin 36 beta |
U: 1
|
| IL36RN | interleukin 36 receptor antagonist |
U: 2
|
| IL4 | interleukin 4 |
U: 4
|
| IL4R | interleukin 4 receptor |
U: 2
D: 2
|
| IL5 | interleukin 5 |
U: 1
|
| IL6 | interleukin 6 |
U: 97
D: 20
|
| IL6ST | interleukin 6 signal transducer |
U: 2
D: 1
|
| IL9 | interleukin 9 |
D: 1
|
| IRAK2 | interleukin-1 receptor-associated kinase 2 |
U: 2
D: 2
|
| IRF3 | interferon regulatory factor 3 |
U: 3
|
| ITGA2 | integrin alpha 2 |
U: 2
D: 3
|
| IER3 | immediate early response 3 |
U: 3
D: 3
|
| ITGAM | integrin alpha M |
U: 1
D: 1
|
| ITGAV | integrin alpha V |
U: 2
D: 1
|
| JAK2 | Janus kinase 2 |
U: 3
|
| KDM6B | KDM1 lysine (K)-specific demethylase 6B |
U: 10
D: 1
|
| KIT | KIT proto-oncogene receptor tyrosine kinase |
U: 1
D: 2
|
| KLF4 | Kruppel like factor 4 |
U: 3
D: 7
|
| KLRG1 | killer cell lectin like receptor G1 |
U: 1
D: 1
|
| KNG1 | kininogen 1 |
U: 2
|
| KPNA6 | karyopherin (importin) alpha 6 |
U: 2
|
| KRT1 | keratin 1 |
U: 1
|
| KRT16 | keratin 16 |
U: 1
|
| KARS | lysyl-tRNA synthetase |
D: 1
|
| KL | klotho |
U: 2
D: 10
|
| LDLR | low density lipoprotein receptor |
U: 3
D: 2
|
| LEP | leptin |
U: 3
D: 1
|
| LGALS9 | lectin, galactose binding, soluble 9 |
U: 3
D: 2
|
| LIAS | lipoic acid synthetase |
D: 1
|
| LIPA | lysosomal acid lipase A |
U: 2
|
| LOXL3 | lysyl oxidase-like 3 |
D: 2
|
| LPL | lipoprotein lipase |
U: 1
D: 3
|
| LRFN5 | leucine rich repeat and fibronectin type III domain containing 5 |
U: 2
|
| LTA | lymphotoxin A |
U: 1
|
| LTB4R | leukotriene B4 receptor |
U: 3
|
| LTB4R2 | leukotriene B4 receptor 2 |
U: 2
D: 2
|
| LXN | latexin |
D: 3
|
| LY96 | lymphocyte antigen 96 |
U: 1
|
| LYN | LYN proto-oncogene, Src family tyrosine kinase |
D: 1
|
| MACIR | macrophage immunometabolism regulator | |
| MAP2K3 | mitogen-activated protein kinase kinase 3 |
U: 5
D: 1
|
| MAPK13 | mitogen-activated protein kinase 13 |
U: 2
D: 2
|
| MAPK14 | mitogen-activated protein kinase 14 |
U: 44
D: 6
|
| MAPK7 | mitogen-activated protein kinase 7 |
D: 1
|
| MAPKAPK2 | MAP kinase-activated protein kinase 2 |
U: 2
D: 1
|
| MDK | midkine |
U: 2
D: 2
|
| METRNL | meteorin, glial cell differentiation regulator-like |
U: 1
D: 1
|
| MFHAS1 | malignant fibrous histiocytoma amplified sequence 1 |
U: 1
D: 2
|
| MGLL | monoglyceride lipase |
U: 1
D: 2
|
| MIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
U: 3
D: 5
|
| MIR125A | microRNA 125a |
U: 1
|
| MIR126 | microRNA 126 |
U: 1
D: 2
|
| MIR136 | microRNA 136 |
U: 1
|
| MIR138-1 | microRNA 138-1 |
U: 1
|
| MIR140 | microRNA 140 |
U: 1
|
| MIR141 | microRNA 141 |
U: 2
|
| MIR145 | microRNA 145 |
U: 1
|
| MIR146A | microRNA 146a |
U: 2
D: 5
|
| MIR149 | microRNA 149 |
U: 1
|
| MIR16-1 | microRNA 16-1 |
U: 1
|
| MIR17 | microRNA 17 |
D: 1
|
| MIR181A1 | microRNA 181a-1 |
U: 2
|
| MIR181A2 | microRNA 181a-2 |
U: 1
|
| MIR181B1 | microRNA 181b-1 |
U: 1
|
| MIR197 | microRNA 197 |
U: 1
|
| MIR19B1 | microRNA 19b-1 |
U: 1
|
| MIR203A | microRNA 203a |
U: 2
|
| MIR205 | microRNA 205 |
U: 2
D: 1
|
| MIR20A | microRNA 20a | |
| MIR21 | microRNA 21 |
U: 2
D: 1
|
| MIR22 | microRNA 22 |
U: 8
|
| MIR221 | microRNA 221 |
D: 1
|
| MIR222 | microRNA 222 |
U: 1
|
| MIR31 | microRNA 31 |
U: 1
D: 1
|
| MIR590 | microRNA 590 |
D: 1
|
| MIR98 | microRNA 98 |
D: 1
|
| MSMP | microseminoprotein, prostate associated |
U: 1
|
| MVK | mevalonate kinase |
U: 4
D: 1
|
| MYD88 | myeloid differentiation primary response gene 88 |
U: 1
|
| MYLK3 | myosin light chain kinase 3 |
U: 1
D: 1
|
| MAPK8 | mitogen-activated protein kinase 8 |
U: 5
D: 3
|
| MECOM | MDS1 and EVI1 complex locus |
U: 2
D: 4
|
| MIR155 | microRNA 155 |
U: 1
|
| MIR21A | microRNA 21a |
U: 1
|
| MIR324 | microRNA 324 |
U: 1
D: 2
|
| MUC19 | mucin 19 |
U: 1
|
| NDST1 | N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 |
U: 2
|
| NEAT1 | nuclear paraspeckle assembly transcript 1 |
U: 2
D: 1
|
| NFATC4 | nuclear factor of activated T cells 4 |
U: 2
D: 1
|
| NFE2L1 | nuclear factor, erythroid derived 2,-like 1 |
U: 1
|
| NFE2L2 | nuclear factor, erythroid derived 2, like 2 |
U: 4
D: 16
|
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
U: 19
D: 7
|
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
U: 2
D: 6
|
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta |
U: 1
D: 2
|
| NFRKB | nuclear factor related to kappaB binding protein |
D: 1
|
| NFX1 | nuclear transcription factor, X-box binding 1 |
D: 1
|
| NLRC4 | NLR family, CARD domain containing 4 |
U: 2
|
| NLRP1 | NLR family pyrin domain containing 1 |
U: 1
D: 1
|
| NLRP2 | NLR family pyrin domain containing 2 |
U: 1
|
| NLRP3 | NLR family, pyrin domain containing 3 |
U: 6
|
| NLRX1 | NLR family member X1 |
U: 3
|
| NMI | N-myc and STAT interactor |
U: 1
|
| NOD1 | nucleotide binding oligomerization domain containing 1 |
D: 2
|
| NOD2 | nucleotide-binding oligomerization domain containing 2 |
U: 1
D: 1
|
| NOS2 | nitric oxide synthase 2, inducible |
U: 7
D: 2
|
| NOTCH1 | notch 1 |
U: 8
D: 5
|
| NOX1 | NADPH oxidase 1 |
U: 6
|
| NOX4 | NADPH oxidase 4 |
U: 18
D: 2
|
| NPFF | neuropeptide FF-amide peptide precursor |
U: 1
|
| NR1D1 | nuclear receptor subfamily 1, group D, member 1 |
U: 2
D: 1
|
| NR1D2 | nuclear receptor subfamily 1, group D, member 2 |
U: 1
|
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 |
D: 3
|
| NRROS | negative regulator of reactive oxygen species |
U: 2
|
| NT5E | 5' nucleotidase, ecto |
U: 1
D: 2
|
| NUPR1 | nuclear protein transcription regulator 1 |
U: 6
D: 2
|
| NDUFS4 | NADH:ubiquinone oxidoreductase core subunit S4 |
U: 1
|
| OGG1 | 8-oxoguanine DNA glycosylase |
U: 1
D: 7
|
| OLR1 | oxidized low density lipoprotein (lectin-like) receptor 1 |
U: 3
|
| OSM | oncostatin M |
U: 1
|
| OSMR | oncostatin M receptor |
U: 1
D: 1
|
| P2RX7 | purinergic receptor P2X, ligand-gated ion channel, 7 |
D: 1
|
| PARK7 | Parkinson disease (autosomal recessive, early onset) 7 |
U: 1
D: 2
|
| PARP4 | poly (ADP-ribose) polymerase family, member 4 |
U: 1
D: 1
|
| PBK | PDZ binding kinase |
D: 6
|
| PDCD4 | programmed cell death 4 |
U: 2
D: 1
|
| PDE2A | phosphodiesterase 2A, cGMP-stimulated |
U: 1
D: 3
|
| PER1 | period circadian clock 1 |
U: 1
D: 1
|
| PF4 | platelet factor 4 |
U: 3
D: 1
|
| PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 |
U: 1
D: 1
|
| PIK3CD | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
U: 2
D: 2
|
| PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
U: 2
D: 3
|
| PJA2 | praja ring finger ubiquitin ligase 2 |
U: 1
D: 1
|
| PLA2G2A | phospholipase A2 group IIA |
U: 2
|
| PLA2G4C | phospholipase A2 group IVC |
U: 2
|
| PLAA | phospholipase A2, activating protein |
U: 2
|
| PLD3 | phospholipase D family, member 3 |
U: 3
|
| PLGRKT | plasminogen receptor, C-terminal lysine transmembrane protein |
D: 1
|
| PLP1 | proteolipid protein (myelin) 1 |
D: 2
|
| PNMA1 | paraneoplastic antigen MA1 |
D: 1
|
| POLB | polymerase (DNA directed), beta |
D: 1
|
| PPARA | peroxisome proliferator activated receptor alpha |
D: 8
|
| PPARD | peroxisome proliferator activator receptor delta |
U: 3
D: 4
|
| PPARG | peroxisome proliferator activated receptor gamma |
U: 7
D: 9
|
| PPBP | pro-platelet basic protein |
U: 3
|
| PRDX2 | peroxiredoxin 2 |
U: 1
D: 3
|
| PRKCD | protein kinase C delta |
U: 7
|
| PRKCQ | protein kinase C, theta |
U: 1
|
| PRKCZ | protein kinase C, zeta |
D: 1
|
| PRKD1 | protein kinase D1 |
U: 2
D: 1
|
| PROC | protein C |
U: 1
|
| PTGDR | prostaglandin D receptor | |
| PTGER2 | prostaglandin E receptor 2 (subtype EP2) |
D: 5
|
| PTGER4 | prostaglandin E receptor 4 (subtype EP4) |
U: 3
D: 2
|
| PTGES | prostaglandin E synthase |
U: 2
D: 1
|
| PTGFR | prostaglandin F receptor |
D: 1
|
| PTGIR | prostaglandin I receptor (IP) |
U: 1
|
| PTGIS | prostaglandin I2 (prostacyclin) synthase |
U: 2
D: 2
|
| PTGS1 | prostaglandin-endoperoxide synthase 1 |
U: 2
D: 2
|
| PTGS2 | prostaglandin-endoperoxide synthase 2 |
U: 12
D: 4
|
| PTN | pleiotrophin |
U: 2
D: 6
|
| PTPN2 | protein tyrosine phosphatase, non-receptor type 2 |
U: 1
D: 1
|
| PTX3 | pentraxin 3 |
U: 6
|
| PXK | PX domain containing serine/threonine kinase |
D: 2
|
| PYCARD | PYD and CARD domain containing |
U: 1
|
| PDE5A | phosphodiesterase 5A, cGMP-specific |
U: 1
D: 1
|
| PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) |
U: 1
D: 1
|
| PLA2G5 | phospholipase A2, group V |
U: 1
D: 1
|
| PMP22 | peripheral myelin protein 22 |
U: 2
D: 1
|
| PRKCA | protein kinase C, alpha |
U: 3
D: 3
|
| RAC1 | Rac family small GTPase 1 |
U: 5
D: 3
|
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 |
U: 1
D: 3
|
| RB1 | RB transcriptional corepressor 1 |
U: 37
D: 7
|
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region |
D: 2
|
| REL | reticuloendotheliosis oncogene |
U: 2
D: 1
|
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
U: 12
D: 5
|
| RELB | avian reticuloendotheliosis viral (v-rel) oncogene related B |
U: 2
D: 1
|
| RICTOR | RPTOR independent companion of MTOR, complex 2 |
U: 2
|
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 |
U: 1
|
| RIPK2 | receptor interacting serine/threonine kinase 2 |
U: 1
D: 1
|
| RORA | RAR-related orphan receptor alpha |
U: 5
|
| RPS19 | ribosomal protein S19 |
U: 2
D: 1
|
| RPS6KA5 | ribosomal protein S6 kinase, polypeptide 5 |
U: 2
D: 2
|
| S100A8 | S100 calcium binding protein A8 (calgranulin A) |
U: 2
|
| S100A9 | S100 calcium binding protein A9 (calgranulin B) |
U: 2
D: 1
|
| S1PR3 | sphingosine-1-phosphate receptor 3 |
D: 3
|
| SAA1 | serum amyloid A1 |
U: 5
|
| SBNO2 | strawberry notch 2 |
U: 1
D: 1
|
| SCG2 | secretogranin II |
U: 1
|
| SCGB1A1 | secretoglobin, family 1A, member 1 (uteroglobin) |
D: 1
|
| SCN9A | sodium channel, voltage-gated, type IX, alpha |
U: 1
|
| SCUBE1 | signal peptide, CUB domain and EGF like domain containing 1 |
D: 1
|
| SDC1 | syndecan 1 |
U: 5
D: 1
|
| SEH1L | SEH1-like (S. cerevisiae |
U: 1
D: 2
|
| SELE | selectin, endothelial cell |
U: 1
|
| SELENOS | selenoprotein S |
D: 1
|
| SELP | selectin, platelet |
U: 1
D: 1
|
| SEMA7A | sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A |
U: 2
D: 2
|
| SERPINA3 | serpin family A member 3 |
U: 4
|
| SERPINC1 | serpin family C member 1 | |
| SERPINE1 | serine (or cysteine) peptidase inhibitor, clade E, member 1 |
U: 38
D: 5
|
| SERPINF1 | serine (or cysteine) peptidase inhibitor, clade F, member 1 |
U: 5
D: 3
|
| SGMS1 | sphingomyelin synthase 1 |
U: 1
D: 1
|
| SIRPA | signal-regulatory protein alpha |
U: 2
D: 1
|
| SLAMF8 | SLAM family member 8 |
U: 2
D: 1
|
| SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 |
U: 1
|
| SLC7A2 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
D: 2
|
| SMAD1 | SMAD family member 1 |
U: 1
D: 1
|
| SMAD3 | SMAD family member 3 |
U: 8
D: 2
|
| SMPDL3B | sphingomyelin phosphodiesterase, acid-like 3B |
U: 1
|
| SNCA | synuclein, alpha |
U: 3
|
| SOCS3 | suppressor of cytokine signaling 3 |
U: 1
D: 5
|
| SOD1 | superoxide dismutase 1, soluble |
U: 5
D: 4
|
| SPATA2 | spermatogenesis associated 2 |
U: 1
|
| SPHK1 | sphingosine kinase 1 |
U: 3
D: 2
|
| SPP1 | secreted phosphoprotein 1 |
U: 4
D: 2
|
| STAB1 | stabilin 1 |
D: 1
|
| STARD7 | START domain containing 7 |
U: 1
|
| STAT3 | signal transducer and activator of transcription 3 |
U: 18
D: 6
|
| STAT5B | signal transducer and activator of transcription 5B |
U: 4
|
| STING1 | stimulator of interferon response cGAMP interactor 1 |
U: 2
|
| STK39 | serine/threonine kinase 39 |
D: 2
|
| SERPINB9 | serine (or cysteine) peptidase inhibitor, clade B, member 9 |
D: 1
|
| SLIT2 | slit guidance ligand 2 |
U: 1
D: 1
|
| STAT5A | signal transducer and activator of transcription 5A |
U: 6
D: 2
|
| TAC1 | tachykinin 1 |
U: 1
|
| TACR1 | tachykinin receptor 1 |
D: 1
|
| TBC1D23 | TBC1 domain family, member 23 |
D: 1
|
| TBK1 | TANK binding kinase 1 |
U: 2
|
| TBXA2R | thromboxane A2 receptor |
U: 1
D: 1
|
| TCIRG1 | T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 |
U: 1
D: 1
|
| TEK | TEK receptor tyrosine kinase |
D: 3
|
| TGFB1 | transforming growth factor, beta 1 |
U: 49
D: 6
|
| TGM2 | transglutaminase 2, C polypeptide |
U: 6
D: 1
|
| THBS1 | thrombospondin 1 |
U: 7
D: 4
|
| THEMIS2 | thymocyte selection associated family member 2 |
U: 2
|
| TICAM1 | toll-like receptor adaptor molecule 1 |
U: 1
|
| TIMP1 | tissue inhibitor of metalloproteinase 1 |
U: 10
D: 3
|
| TLR1 | toll-like receptor 1 |
U: 2
|
| TLR10 | toll like receptor 10 |
U: 1
|
| TLR2 | toll-like receptor 2 |
U: 3
D: 1
|
| TLR3 | toll-like receptor 3 |
U: 4
D: 1
|
| TLR4 | toll-like receptor 4 |
U: 7
D: 2
|
| TLR5 | toll-like receptor 5 |
U: 1
D: 1
|
| TLR6 | toll-like receptor 6 |
U: 1
D: 1
|
| TLR9 | toll-like receptor 9 |
U: 1
D: 1
|
| TMSB4X | thymosin beta 4 X-linked |
D: 3
|
| TNF | tumor necrosis factor |
U: 48
D: 7
|
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
U: 3
D: 1
|
| TNFAIP6 | tumor necrosis factor alpha induced protein 6 |
U: 2
|
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1a |
U: 4
D: 2
|
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1b |
U: 3
D: 3
|
| TNFSF4 | tumor necrosis factor (ligand) superfamily, member 4 |
U: 1
D: 1
|
| TNIP1 | TNFAIP3 interacting protein 1 |
U: 2
|
| TNIP2 | TNFAIP3 interacting protein 2 |
U: 1
|
| TNIP3 | TNFAIP3 interacting protein 3 |
U: 1
D: 1
|
| TOLLIP | toll interacting protein |
U: 2
|
| TPST1 | tyrosylprotein sulfotransferase 1 |
D: 1
|
| TRADD | TNFRSF1A-associated via death domain |
U: 1
|
| TREM1 | triggering receptor expressed on myeloid cells 1 |
U: 2
|
| TREX1 | three prime repair exonuclease 1 |
U: 1
D: 2
|
| TRIL | TLR4 interactor with leucine-rich repeats |
D: 2
|
| TRPV4 | transient receptor potential cation channel, subfamily V, member 4 |
U: 1
|
| TSLP | thymic stromal lymphopoietin |
U: 1
D: 1
|
| TSPAN2 | tetraspanin 2 |
U: 2
D: 1
|
| TUSC2 | tumor suppressor 2, mitochondrial calcium regulator |
U: 2
|
| TYRO3 | TYRO3 protein tyrosine kinase 3 |
U: 1
D: 2
|
| TNFSF18 | tumor necrosis factor (ligand) superfamily, member 18 |
U: 1
|
| TRIM55 | tripartite motif-containing 55 |
U: 1
|
| TRP73 | transformation related protein 73 |
D: 3
|
| UCN | urocortin |
U: 1
|
| USP18 | ubiquitin specific peptidase 18 |
U: 2
D: 1
|
| UACA | uveal autoantigen with coiled-coil domains and ankyrin repeats |
U: 1
D: 3
|
| VNN1 | vanin 1 |
U: 2
D: 2
|
| VPS35 | VPS35 retromer complex component |
U: 1
|
| WFDC1 | WAP four-disulfide core domain 1 |
U: 1
|
| WNT5A | wingless-type MMTV integration site family, member 5A |
U: 4
|
| XCL1 | chemokine (C motif) ligand 1 |
U: 1
D: 1
|
| XIAP | X-linked inhibitor of apoptosis |
U: 2
D: 1
|
| ZC3H12A | zinc finger CCCH type containing 12A |
U: 3
D: 1
|
| ZYX | zyxin |
U: 5
D: 2
|
| ZFP36 | zinc finger protein 36 |
U: 3
D: 4
|